» Articles » PMID: 35454768

Measurement of Perfusion Heterogeneity Within Tumor Habitats on Magnetic Resonance Imaging and Its Association with Prognosis in Breast Cancer Patients

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2022 Apr 23
PMID 35454768
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of this study was to identify perfusional subregions sharing similar kinetic characteristics from dynamic contrast-enhanced magnetic resonance imaging (MRI) using data-driven clustering, and to evaluate the effect of perfusional heterogeneity based on those subregions on patients' survival outcomes in various risk models. From two hospitals, 308 and 147 women with invasive breast cancer who underwent preoperative MRI between October 2011 and July 2012 were retrospectively enrolled as development and validation cohorts, respectively. Using the Cox-least absolute shrinkage and selection operator model, a habitat risk score (HRS) was constructed from the radiomics features from the derived habitat map. An HRS-only, clinical, combined habitat, and two conventional radiomics risk models to predict patients' disease-free survival (DFS) were built. Patients were classified into low-risk or high-risk groups using the median cutoff values of each risk score. Five habitats with distinct perfusion patterns were identified. An HRS was an independent risk factor for predicting worse DFS outcomes in the HRS-only risk model (hazard ratio = 3.274 [95% CI = 1.378-7.782]; = 0.014) and combined habitat risk model (hazard ratio = 4.128 [95% CI = 1.744-9.769]; = 0.003) in the validation cohort. In the validation cohort, the combined habitat risk model (hazard ratio = 4.128, = 0.003, C-index = 0.760) showed the best performance among five different risk models. The quantification of perfusion heterogeneity is a potential approach for predicting prognosis and may facilitate personalized, tailored treatment strategies for breast cancer.

Citing Articles

To accurately predict lymph node metastasis in patients with mass-forming intrahepatic cholangiocarcinoma by using CT radiomics features of tumor habitat subregions.

Chen P, Yang Z, Ning P, Yuan H, Qi Z, Li Q Cancer Imaging. 2025; 25(1):19.

PMID: 40011960 PMC: 11863903. DOI: 10.1186/s40644-025-00842-8.


Evaluating dynamic contrast-enhanced MRI for differentiating HER2-zero, HER2-low, and HER2-positive breast cancers in patients undergoing neoadjuvant chemotherapy.

Hu Y, Li M, Hu Y, Wang M, Lin Y, Mao L Eur J Med Res. 2025; 30(1):132.

PMID: 40001120 PMC: 11852569. DOI: 10.1186/s40001-024-02188-6.


High-risk habitat radiomics model based on ultrasound images for predicting lateral neck lymph node metastasis in differentiated thyroid cancer.

Liu H, Hou C, Wei M, Lu K, Liu Y, Du P BMC Med Imaging. 2025; 25(1):16.

PMID: 39806311 PMC: 11727229. DOI: 10.1186/s12880-025-01551-1.


F-FDG PET/CT-based habitat radiomics combining stacking ensemble learning for predicting prognosis in hepatocellular carcinoma: a multi-center study.

Sui C, Su Q, Chen K, Tan R, Wang Z, Liu Z BMC Cancer. 2024; 24(1):1457.

PMID: 39604895 PMC: 11600565. DOI: 10.1186/s12885-024-13206-5.


Unveiling Tim-3 immune checkpoint expression in hepatocellular carcinoma through abdominal contrast-enhanced CT habitat radiomics.

Tang Z, Wang W, Gao B, Liu X, Liu X, Zhuo Y Front Oncol. 2024; 14:1456748.

PMID: 39582537 PMC: 11581969. DOI: 10.3389/fonc.2024.1456748.


References
1.
Junttila M, de Sauvage F . Influence of tumour micro-environment heterogeneity on therapeutic response. Nature. 2013; 501(7467):346-54. DOI: 10.1038/nature12626. View

2.
Nam S, Ko E, Lim Y, Han B, Ko E, Choi J . Preoperative dynamic breast magnetic resonance imaging kinetic features using computer-aided diagnosis: Association with survival outcome and tumor aggressiveness in patients with invasive breast cancer. PLoS One. 2018; 13(4):e0195756. PMC: 5896992. DOI: 10.1371/journal.pone.0195756. View

3.
Kim J, Kim J, Hwangbo L, Suh H, Kim S, Choo K . Kinetic Heterogeneity of Breast Cancer Determined Using Computer-aided Diagnosis of Preoperative MRI Scans: Relationship to Distant Metastasis-Free Survival. Radiology. 2020; 295(3):517-526. DOI: 10.1148/radiol.2020192039. View

4.
Kim J, Ko E, Lim Y, Lee K, Han B, Ko E . Breast Cancer Heterogeneity: MR Imaging Texture Analysis and Survival Outcomes. Radiology. 2016; 282(3):665-675. DOI: 10.1148/radiol.2016160261. View

5.
Koren S, Bentires-Alj M . Breast Tumor Heterogeneity: Source of Fitness, Hurdle for Therapy. Mol Cell. 2015; 60(4):537-46. DOI: 10.1016/j.molcel.2015.10.031. View